Cost–Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low-Dose Acetylsalicylic Acid Treatment

BACKGROUND: In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs Aging
Autors principals: Chau, Sek Hung, Sluiter, Reinier Luuk, Hugtenburg, Jacqueline Geertruida, Wensing, Michel, Kievit, Wietske, Teichert, Martina
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965335/
https://ncbi.nlm.nih.gov/pubmed/31560115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-019-00713-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars